- Systems changes that would be significant for the pharmaceutical & healthcare industry.
- Future scenarios in areas such as pharmaceutical R&D & education
Jay Herson, Ph.D. explores the future of pharmaceutical clinical trials and other systems changes that would be significant for the pharmaceutical and healthcare industry.
Herson is trained as a biostatistician and has knowledge of Bayesian and other cutting-edge statistical methods. He has developed some methods from his experience in contract research and with the M.D. Anderson Cancer Center. Herson founded a successful contract research organization. He serves as an adjunct faculty member in the Department of Biostatistics. He also continues to work on data monitoring for several pharmaceutical, biotech and medical device firms.
Herson is building on growing interest in applying futures methods to understanding clinical development and the pharmaceutical industry. He has published futures articles on these topics. He has been Managing Editor of the newsletter Future Takes.
Herson will be working with IAF to launch a new initiative on The Pharmaceutical Industry 2029. The project will look at a range of topics including new methods of study and analysis in clinical trials, changes in the roles and relationships in research, and the technologies that will be used in research. This initiative also will probe larger global and health system changes that will affect pharma R&D, such as globalization, regulatory and legislative changes, and insurance industry influences.